Literature DB >> 30332629

The Nuclear Receptor PPARγ Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory.

Bence Daniel1, Gergely Nagy2, Zsolt Czimmerer2, Attila Horvath2, David W Hammers3, Ixchelt Cuaranta-Monroy2, Szilard Poliska2, Petros Tzerpos2, Zsuzsanna Kolostyak2, Tristan T Hays1, Andreas Patsalos1, René Houtman4, Sascha Sauer5, Jean Francois-Deleuze6, Fraydoon Rastinejad1, Balint L Balint2, H Lee Sweeney3, Laszlo Nagy7.   

Abstract

Macrophages polarize into distinct phenotypes in response to complex environmental cues. We found that the nuclear receptor PPARγ drove robust phenotypic changes in macrophages upon repeated stimulation with interleukin (IL)-4. The functions of PPARγ on macrophage polarization in this setting were independent of ligand binding. Ligand-insensitive PPARγ bound DNA and recruited the coactivator P300 and the architectural protein RAD21. This established a permissive chromatin environment that conferred transcriptional memory by facilitating the binding of the transcriptional regulator STAT6 and RNA polymerase II, leading to robust production of enhancer and mRNAs upon IL-4 re-stimulation. Ligand-insensitive PPARγ binding controlled the expression of an extracellular matrix remodeling-related gene network in macrophages. Expression of these genes increased during muscle regeneration in a mouse model of injury, and this increase coincided with the detection of IL-4 and PPARγ in the affected tissue. Thus, a predominantly ligand-insensitive PPARγ:RXR cistrome regulates progressive and/or reinforcing macrophage polarization.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IFN-γ; IL-4; Nuclear receptor; PPARγ; coregulators; epigenomics; ligand-insensitive enhancers; macrophage polarization; muscle regeneration; progressive polarization; transcriptional memory

Mesh:

Substances:

Year:  2018        PMID: 30332629      PMCID: PMC6197058          DOI: 10.1016/j.immuni.2018.09.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  43 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

3.  Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.

Authors:  S Hauser; G Adelmant; P Sarraf; H M Wright; E Mueller; B M Spiegelman
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF.

Authors:  Kyuho Kang; Sung Ho Park; Janice Chen; Yu Qiao; Eugenia Giannopoulou; Karen Berg; Adedayo Hanidu; Jun Li; Gerald Nabozny; Keunsoo Kang; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

5.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

6.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

Authors:  Minna U Kaikkonen; Nathanael J Spann; Sven Heinz; Casey E Romanoski; Karmel A Allison; Joshua D Stender; Hyun B Chun; David F Tough; Rab K Prinjha; Christopher Benner; Christopher K Glass
Journal:  Mol Cell       Date:  2013-08-08       Impact factor: 17.970

7.  Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.

Authors:  Sonia E Step; Hee-Woong Lim; Jill M Marinis; Andreas Prokesch; David J Steger; Seo-Hee You; Kyoung-Jae Won; Mitchell A Lazar
Journal:  Genes Dev       Date:  2014-05-01       Impact factor: 11.361

8.  Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation.

Authors:  Sung Ho Park; Kyuho Kang; Eugenia Giannopoulou; Yu Qiao; Keunsoo Kang; Geonho Kim; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2017-08-21       Impact factor: 25.606

Review 9.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03

10.  The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages.

Authors:  Zsolt Czimmerer; Bence Daniel; Attila Horvath; Dominik Rückerl; Gergely Nagy; Mate Kiss; Matthew Peloquin; Marietta M Budai; Ixchelt Cuaranta-Monroy; Zoltan Simandi; Laszlo Steiner; Bela Nagy; Szilard Poliska; Csaba Banko; Zsolt Bacso; Ira G Schulman; Sascha Sauer; Jean-Francois Deleuze; Judith E Allen; Szilvia Benko; Laszlo Nagy
Journal:  Immunity       Date:  2018-01-16       Impact factor: 31.745

View more
  42 in total

Review 1.  Control of Stimulus-Dependent Responses in Macrophages by SWI/SNF Chromatin Remodeling Complexes.

Authors:  Jovylyn Gatchalian; Jingwen Liao; Matthew B Maxwell; Diana C Hargreaves
Journal:  Trends Immunol       Date:  2020-01-09       Impact factor: 16.687

2.  Alternative Activation of Macrophages Is Accompanied by Chromatin Remodeling Associated with Lineage-Dependent DNA Shape Features Flanking PU.1 Motifs.

Authors:  Mei San Tang; Emily R Miraldi; Natasha M Girgis; Richard A Bonneau; P'ng Loke
Journal:  J Immunol       Date:  2020-07-13       Impact factor: 5.422

Review 3.  Transcriptional and epigenetic regulation of macrophages in atherosclerosis.

Authors:  Tatyana Kuznetsova; Koen H M Prange; Christopher K Glass; Menno P J de Winther
Journal:  Nat Rev Cardiol       Date:  2019-10-02       Impact factor: 32.419

4.  Unraveling the Hierarchy of cis and trans Factors That Determine the DNA Binding by Peroxisome Proliferator-Activated Receptor γ.

Authors:  Gergely Nagy; Bence Daniel; Ixchelt Cuaranta-Monroy; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2020-03-16       Impact factor: 4.272

5.  Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor.

Authors:  Lina Fadel; Bálint Rehó; Julianna Volkó; Dóra Bojcsuk; Zsuzsanna Kolostyák; Gergely Nagy; Gabriele Müller; Zoltan Simandi; Éva Hegedüs; Gábor Szabó; Katalin Tóth; Laszlo Nagy; György Vámosi
Journal:  J Biol Chem       Date:  2020-06-08       Impact factor: 5.157

Review 6.  Adaptation and memory in immune responses.

Authors:  Gioacchino Natoli; Renato Ostuni
Journal:  Nat Immunol       Date:  2019-06-18       Impact factor: 25.606

7.  Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.

Authors:  Hannah E Wilson; David A Stanton; Stephanie Rellick; Werner Geldenhuys; Emidio E Pistilli
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-13       Impact factor: 4.249

Review 8.  The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD.

Authors:  Emmanuel D Dixon; Alexander D Nardo; Thierry Claudel; Michael Trauner
Journal:  Genes (Basel)       Date:  2021-04-26       Impact factor: 4.096

Review 9.  Interferon target-gene expression and epigenomic signatures in health and disease.

Authors:  Franck J Barrat; Mary K Crow; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606

Review 10.  The role of peroxisome proliferator-activated receptors (PPAR) in immune responses.

Authors:  Anthos Christofides; Eirini Konstantinidou; Chinmay Jani; Vassiliki A Boussiotis
Journal:  Metabolism       Date:  2020-08-11       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.